List of Tables
Table 1. Circulating Tumor Cells Market Trends
Table 2. Circulating Tumor Cells Market Drivers & Opportunity
Table 3. Circulating Tumor Cells Market Challenges
Table 4. Circulating Tumor Cells Market Restraints
Table 5. Global Circulating Tumor Cells Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Circulating Tumor Cells Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Circulating Tumor Cells Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Circulating Tumor Cells Product Type
Table 9. Key Companies Time to Begin Mass Production of Circulating Tumor Cells
Table 10. Global Circulating Tumor Cells Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cells as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Circulating Tumor Cells Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Circulating Tumor Cells Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Circulating Tumor Cells Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Circulating Tumor Cells Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Circulating Tumor Cells Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Circulating Tumor Cells Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Circulating Tumor Cells Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Circulating Tumor Cells Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Circulating Tumor Cells Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Circulating Tumor Cells Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Circulating Tumor Cells Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Circulating Tumor Cells Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Circulating Tumor Cells Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Circulating Tumor Cells Sales Value by Region (2019-2024) & (%)
Table 27. Global Circulating Tumor Cells Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Circulating Tumor Cells Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Circulating Tumor Cells Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Circulating Tumor Cells Sales Value, (2025-2030) & (US$ Million)
Table 31. Menarini-Silicon Biosystems Basic Information List
Table 32. Menarini-Silicon Biosystems Description and Business Overview
Table 33. Menarini-Silicon Biosystems Circulating Tumor Cells Products, Services and Solutions
Table 34. Revenue (US$ Million) in Circulating Tumor Cells Business of Menarini-Silicon Biosystems (2019-2024)
Table 35. Menarini-Silicon Biosystems Recent Developments
Table 36. Qiagen (Adnagen) Basic Information List
Table 37. Qiagen (Adnagen) Description and Business Overview
Table 38. Qiagen (Adnagen) Circulating Tumor Cells Products, Services and Solutions
Table 39. Revenue (US$ Million) in Circulating Tumor Cells Business of Qiagen (Adnagen) (2019-2024)
Table 40. Qiagen (Adnagen) Recent Developments
Table 41. Advanced Cell Diagnostics Basic Information List
Table 42. Advanced Cell Diagnostics Description and Business Overview
Table 43. Advanced Cell Diagnostics Circulating Tumor Cells Products, Services and Solutions
Table 44. Revenue (US$ Million) in Circulating Tumor Cells Business of Advanced Cell Diagnostics (2019-2024)
Table 45. Advanced Cell Diagnostics Recent Developments
Table 46. ApoCell Basic Information List
Table 47. ApoCell Description and Business Overview
Table 48. ApoCell Circulating Tumor Cells Products, Services and Solutions
Table 49. Revenue (US$ Million) in Circulating Tumor Cells Business of ApoCell (2019-2024)
Table 50. ApoCell Recent Developments
Table 51. Epic Sciences Basic Information List
Table 52. Epic Sciences Description and Business Overview
Table 53. Epic Sciences Circulating Tumor Cells Products, Services and Solutions
Table 54. Revenue (US$ Million) in Circulating Tumor Cells Business of Epic Sciences (2019-2024)
Table 55. Epic Sciences Recent Developments
Table 56. Greiner Bio-one GmbH Basic Information List
Table 57. Greiner Bio-one GmbH Description and Business Overview
Table 58. Greiner Bio-one GmbH Circulating Tumor Cells Products, Services and Solutions
Table 59. Revenue (US$ Million) in Circulating Tumor Cells Business of Greiner Bio-one GmbH (2019-2024)
Table 60. Greiner Bio-one GmbH Recent Developments
Table 61. Cynvenio Basic Information List
Table 62. Cynvenio Description and Business Overview
Table 63. Cynvenio Circulating Tumor Cells Products, Services and Solutions
Table 64. Revenue (US$ Million) in Circulating Tumor Cells Business of Cynvenio (2019-2024)
Table 65. Cynvenio Recent Developments
Table 66. SurExamBio-Tech Basic Information List
Table 67. SurExamBio-Tech Description and Business Overview
Table 68. SurExamBio-Tech Circulating Tumor Cells Products, Services and Solutions
Table 69. Revenue (US$ Million) in Circulating Tumor Cells Business of SurExamBio-Tech (2019-2024)
Table 70. SurExamBio-Tech Recent Developments
Table 71. Fluxion Biosciences Basic Information List
Table 72. Fluxion Biosciences Description and Business Overview
Table 73. Fluxion Biosciences Circulating Tumor Cells Products, Services and Solutions
Table 74. Revenue (US$ Million) in Circulating Tumor Cells Business of Fluxion Biosciences (2019-2024)
Table 75. Fluxion Biosciences Recent Developments
Table 76. Ikonisys Basic Information List
Table 77. Ikonisys Description and Business Overview
Table 78. Ikonisys Circulating Tumor Cells Products, Services and Solutions
Table 79. Revenue (US$ Million) in Circulating Tumor Cells Business of Ikonisys (2019-2024)
Table 80. Ikonisys Recent Developments
Table 81. Hangzhou Watson Biotech Basic Information List
Table 82. Hangzhou Watson Biotech Description and Business Overview
Table 83. Hangzhou Watson Biotech Circulating Tumor Cells Products, Services and Solutions
Table 84. Revenue (US$ Million) in Circulating Tumor Cells Business of Hangzhou Watson Biotech (2019-2024)
Table 85. Hangzhou Watson Biotech Recent Developments
Table 86. Biocept Basic Information List
Table 87. Biocept Description and Business Overview
Table 88. Biocept Circulating Tumor Cells Products, Services and Solutions
Table 89. Revenue (US$ Million) in Circulating Tumor Cells Business of Biocept (2019-2024)
Table 90. Biocept Recent Developments
Table 91. CytoTrack Basic Information List
Table 92. CytoTrack Description and Business Overview
Table 93. CytoTrack Circulating Tumor Cells Products, Services and Solutions
Table 94. Revenue (US$ Million) in Circulating Tumor Cells Business of CytoTrack (2019-2024)
Table 95. CytoTrack Recent Developments
Table 96. Guangzhou Wondfo Biotech Basic Information List
Table 97. Guangzhou Wondfo Biotech Description and Business Overview
Table 98. Guangzhou Wondfo Biotech Circulating Tumor Cells Products, Services and Solutions
Table 99. Revenue (US$ Million) in Circulating Tumor Cells Business of Guangzhou Wondfo Biotech (2019-2024)
Table 100. Guangzhou Wondfo Biotech Recent Developments
Table 101. Celsee Basic Information List
Table 102. Celsee Description and Business Overview
Table 103. Celsee Circulating Tumor Cells Products, Services and Solutions
Table 104. Revenue (US$ Million) in Circulating Tumor Cells Business of Celsee (2019-2024)
Table 105. Celsee Recent Developments
Table 106. Clearbridge Biomedics Basic Information List
Table 107. Clearbridge Biomedics Description and Business Overview
Table 108. Clearbridge Biomedics Circulating Tumor Cells Products, Services and Solutions
Table 109. Revenue (US$ Million) in Circulating Tumor Cells Business of Clearbridge Biomedics (2019-2024)
Table 110. Clearbridge Biomedics Recent Developments
Table 111. ANGLE plc Basic Information List
Table 112. ANGLE plc Description and Business Overview
Table 113. ANGLE plc Circulating Tumor Cells Products, Services and Solutions
Table 114. Revenue (US$ Million) in Circulating Tumor Cells Business of ANGLE plc (2019-2024)
Table 115. ANGLE plc Recent Developments
Table 116. Key Raw Materials Lists
Table 117. Raw Materials Key Suppliers Lists
Table 118. Circulating Tumor Cells Downstream Customers
Table 119. Circulating Tumor Cells Distributors List
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
Table 123. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Circulating Tumor Cells Product Picture
Figure 2. Global Circulating Tumor Cells Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Circulating Tumor Cells Sales Value (2019-2030) & (US$ Million)
Figure 4. Circulating Tumor Cells Report Years Considered
Figure 5. Global Circulating Tumor Cells Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Circulating Tumor Cells Revenue in 2023
Figure 7. Circulating Tumor Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. CTC Enrichment Picture
Figure 9. CTC Detection Picture
Figure 10. CTC Analysis Picture
Figure 11. Global Circulating Tumor Cells Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Circulating Tumor Cells Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Breast Cancer
Figure 14. Product Picture of Prostate Cancer
Figure 15. Product Picture of Colorectal Cancer
Figure 16. Product Picture of Lung Cancer
Figure 17. Product Picture of Others
Figure 18. Global Circulating Tumor Cells Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Circulating Tumor Cells Sales Value Market Share by Application, 2023 & 2030
Figure 20. North America Circulating Tumor Cells Sales Value (2019-2030) & (US$ Million)
Figure 21. North America Circulating Tumor Cells Sales Value by Country (%), 2023 VS 2030
Figure 22. Europe Circulating Tumor Cells Sales Value (2019-2030) & (US$ Million)
Figure 23. Europe Circulating Tumor Cells Sales Value by Country (%), 2023 VS 2030
Figure 24. Asia Pacific Circulating Tumor Cells Sales Value (2019-2030) & (US$ Million)
Figure 25. Asia Pacific Circulating Tumor Cells Sales Value by Country (%), 2023 VS 2030
Figure 26. South America Circulating Tumor Cells Sales Value (2019-2030) & (US$ Million)
Figure 27. South America Circulating Tumor Cells Sales Value by Country (%), 2023 VS 2030
Figure 28. Middle East & Africa Circulating Tumor Cells Sales Value (2019-2030) & (US$ Million)
Figure 29. Middle East & Africa Circulating Tumor Cells Sales Value by Country (%), 2023 VS 2030
Figure 30. Key Countries/Regions Circulating Tumor Cells Sales Value (%), (2019-2030)
Figure 31. United States Circulating Tumor Cells Sales Value, (2019-2030) & (US$ Million)
Figure 32. United States Circulating Tumor Cells Sales Value by Type (%), 2023 VS 2030
Figure 33. United States Circulating Tumor Cells Sales Value by Application (%), 2023 VS 2030
Figure 34. Europe Circulating Tumor Cells Sales Value, (2019-2030) & (US$ Million)
Figure 35. Europe Circulating Tumor Cells Sales Value by Type (%), 2023 VS 2030
Figure 36. Europe Circulating Tumor Cells Sales Value by Application (%), 2023 VS 2030
Figure 37. China Circulating Tumor Cells Sales Value, (2019-2030) & (US$ Million)
Figure 38. China Circulating Tumor Cells Sales Value by Type (%), 2023 VS 2030
Figure 39. China Circulating Tumor Cells Sales Value by Application (%), 2023 VS 2030
Figure 40. Japan Circulating Tumor Cells Sales Value, (2019-2030) & (US$ Million)
Figure 41. Japan Circulating Tumor Cells Sales Value by Type (%), 2023 VS 2030
Figure 42. Japan Circulating Tumor Cells Sales Value by Application (%), 2023 VS 2030
Figure 43. South Korea Circulating Tumor Cells Sales Value, (2019-2030) & (US$ Million)
Figure 44. South Korea Circulating Tumor Cells Sales Value by Type (%), 2023 VS 2030
Figure 45. South Korea Circulating Tumor Cells Sales Value by Application (%), 2023 VS 2030
Figure 46. Southeast Asia Circulating Tumor Cells Sales Value, (2019-2030) & (US$ Million)
Figure 47. Southeast Asia Circulating Tumor Cells Sales Value by Type (%), 2023 VS 2030
Figure 48. Southeast Asia Circulating Tumor Cells Sales Value by Application (%), 2023 VS 2030
Figure 49. India Circulating Tumor Cells Sales Value, (2019-2030) & (US$ Million)
Figure 50. India Circulating Tumor Cells Sales Value by Type (%), 2023 VS 2030
Figure 51. India Circulating Tumor Cells Sales Value by Application (%), 2023 VS 2030
Figure 52. Circulating Tumor Cells Industrial Chain
Figure 53. Circulating Tumor Cells Manufacturing Cost Structure
Figure 54. Channels of Distribution (Direct Sales, and Distribution)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
